Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was up 1.9% during trading on Thursday . The stock traded as high as $57.57 and last traded at $57.57. Approximately 628 shares traded hands during trading, a decline of 38% from the average daily volume of 1,018 shares. The stock had previously closed at $56.51.
Hikma Pharmaceuticals Price Performance
The business has a 50-day simple moving average of $50.38 and a two-hundred day simple moving average of $50.28.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Are Penny Stocks a Good Fit for Your Portfolio?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
